250 related articles for article (PubMed ID: 14532768)
1. Detection and prognostic value of cytokeratin positive tumor cells in bone marrow of patients with renal cell carcinoma.
Buchner A; Riesenberg R; Kotter I; Crispin A; Hofstetter A; Oberneder R
J Urol; 2003 Nov; 170(5):1747-51. PubMed ID: 14532768
[TBL] [Abstract][Full Text] [Related]
2. [Immunocytochemical detection and prognostic significance of epithelial tumor cells in bone marrow of patients with pancreatic carcinoma].
Thorban S; Roder JD; Pantel K; Siewert JR
Zentralbl Chir; 1996; 121(6):487-9; discussion 490-2. PubMed ID: 8767337
[TBL] [Abstract][Full Text] [Related]
3. Disseminated cytokeratin positive tumor cells in the bone marrow of patients with prostate cancer: detection and prognostic value.
Weckermann D; Müller P; Wawroschek F; Harzmann R; Riethmüller G; Schlimok G
J Urol; 2001 Aug; 166(2):699-703. PubMed ID: 11458120
[TBL] [Abstract][Full Text] [Related]
4. Does the immunocytochemical detection of epithelial cells in bone marrow (micrometastasis) influence the time to biochemical relapse after radical prostatectomy?
Weckermann D; Wawroschek F; Krawczak G; Haude KH; Harzmann R
Urol Res; 1999 Aug; 27(4):285-90. PubMed ID: 10460901
[TBL] [Abstract][Full Text] [Related]
5. [Immunocytochemical detection of tumor cells in bone marrow as a prognostic factor in breast carcinoma].
Merkle E; Bähr J; Henke A; Bühner M; Martus P
Geburtshilfe Frauenheilkd; 1994 Dec; 54(12):662-9. PubMed ID: 7531659
[TBL] [Abstract][Full Text] [Related]
6. Does the immunocytochemical detection of epithelial cells in bone marrow (micrometastasis) influence the time to biochemical relapse after radical prostatectomy?
Weckermann D; Wawroschek F; Krawczak G; Haude KH; Harzmann R
Urol Res; 1999 Oct; 27(5):285-90. PubMed ID: 10644227
[TBL] [Abstract][Full Text] [Related]
7. [Isolated tumor cells in bone marrow predicts reduced survival in lymph node-negative non-small-cell lung cancer].
Passlick B; Kubuschok B; Izbicki JR; Thetter O; Pantel K
Pneumologie; 2000 Aug; 54(8):355-60. PubMed ID: 11008478
[TBL] [Abstract][Full Text] [Related]
8. Micrometastases in bone marrow of patients with suspected pancreatic and ampullary cancer.
van Heek NT; Tascilar M; van Beekveld JL; Drillenburg P; Offerhaus GJ; Gouma DJ
Eur J Surg Oncol; 2001 Dec; 27(8):740-5. PubMed ID: 11735170
[TBL] [Abstract][Full Text] [Related]
9. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer.
Pantel K; Izbicki JR; Angstwurm M; Braun S; Passlick B; Karg O; Thetter O; Riethmüller G
Cancer Res; 1993 Mar; 53(5):1027-31. PubMed ID: 7679945
[TBL] [Abstract][Full Text] [Related]
10. Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancer.
Ohgami A; Mitsudomi T; Sugio K; Tsuda T; Oyama T; Nishida K; Osaki T; Yasumoto K
Ann Thorac Surg; 1997 Aug; 64(2):363-7. PubMed ID: 9262576
[TBL] [Abstract][Full Text] [Related]
11. The presence of bone marrow cytokeratin-immunoreactive cells does not predict outcome in gastric cancer patients.
de Manzoni G; Pelosi G; Pavanel F; Di Leo A; Pedrazzani C; Durante E; Cordiano C; Pasini F
Br J Cancer; 2002 Apr; 86(7):1047-51. PubMed ID: 11953846
[TBL] [Abstract][Full Text] [Related]
12. [Immunocytologic detection of disseminated tumor cells in the peritoneal cavity and bone marrow in patients with pancreatic carcinoma].
Juhl H; Kalthoff H; Krüger U; Schott A; Schreiber HW; Henne-Bruns D; Kremer B
Chirurg; 1994 Dec; 65(12):1111-5. PubMed ID: 7851144
[TBL] [Abstract][Full Text] [Related]
13. Bone-marrow microinvolvement in non-small cell lung cancer is not a reliable indicator of tumour recurrence and prognosis.
Hsu CP SL; Chen CY; Kwang PC; Miao J; Hsia JY; Shai SE
Eur J Surg Oncol; 2000 Nov; 26(7):691-5. PubMed ID: 11078616
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase.
Borgen E; Beiske K; Trachsel S; Nesland JM; Kvalheim G; Herstad TK; Schlichting E; Qvist H; Naume B
J Pathol; 1998 Aug; 185(4):427-34. PubMed ID: 9828843
[TBL] [Abstract][Full Text] [Related]
15. Urokinase plasminogen activator receptor (uPA-R): one potential characteristic of metastatic phenotypes in minimal residual tumor disease.
Allgayer H; Heiss MM; Riesenberg R; Grützner KU; Tarabichi A; Babic R; Schildberg FW
Cancer Res; 1997 Apr; 57(7):1394-9. PubMed ID: 9102229
[TBL] [Abstract][Full Text] [Related]
16. The role of wide-spectrum cytokeratin staining of the bone marrow cores in patients with ductal carcinoma of the breast.
Dunphy CH
Mod Pathol; 1996 Oct; 9(10):955-8. PubMed ID: 9005447
[TBL] [Abstract][Full Text] [Related]
17. [The prognostic significance of tumor cell detection in bone marrow of patients with breast cancer].
Diel IJ; Kaufmann M; Costa SD; Kaul S; Krempien B; Goerner R; Bastert G
Geburtshilfe Frauenheilkd; 1990 Dec; 50(12):923-8. PubMed ID: 1707840
[TBL] [Abstract][Full Text] [Related]
18. A monoclonal antibody cocktail for detection of micrometastatic tumor cells in the bone marrow of breast cancer patients.
Taha M; Ordoñez NG; Kulkarni S; Owen M; Ro JS; Hortobagyi G; Reading CL; Dicke KA; Spitzer G
Bone Marrow Transplant; 1989 May; 4(3):297-303. PubMed ID: 2471564
[TBL] [Abstract][Full Text] [Related]
19. Low frequency epithelial cells in bone marrow aspirates from prostate carcinoma patients are cytogenetically aberrant.
Mueller P; Carroll P; Bowers E; Moore D; Cher M; Presti J; Wessman M; Pallavicini MG
Cancer; 1998 Aug; 83(3):538-46. PubMed ID: 9690547
[TBL] [Abstract][Full Text] [Related]
20. Tumor angiogenesis and micrometastasis in bone marrow of patients with early gastric cancer.
Maehara Y; Hasuda S; Abe T; Oki E; Kakeji Y; Ohno S; Sugimachi K
Clin Cancer Res; 1998 Sep; 4(9):2129-34. PubMed ID: 9748130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
